FDA Announces Discontinuation of Watson Labs Potassium Chloride Injection (ANDA 086210)

The U.S. Food and Drug Administration (FDA) database lists an Abbreviated New Drug Application (ANDA) with the number ANDA086210 submitted by Watson Labs. The application pertains to a potassium chloride product intended for injection. Key details of the product include: - Brand name: Potassium Chloride - Route of administration: Injection - Dosage form: Injectable - Product number: 001 - Reference drug status: No - Marketing status: Discontinued - Active ingredient: Potassium Chloride, strength 3 mEq/mL - Reference standard: No No additional information about the product’s approval status or market availability is provided beyond its discontinued marketing status.